Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR study

Vericiguat was developed for the treatment of symptomatic chronic heart failure (HF) in adult patients with reduced ejection fraction who are stabilized after a recent decompensation event. Guidelines recommend long‐acting nitrates, such as isosorbide mononitrate, for angina prophylaxis in chronic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Boettcher, Michael, Mikus, Gerd, Trenk, Dietmar, Düngen, Hans‐Dirk, Donath, Frank, Werner, Nikos, Karakas, Mahir, Besche, Nina, Schulz‐Burck, Dominik, Gerrits, Mireille, Hung, James, Becker, Corina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099120/
https://www.ncbi.nlm.nih.gov/pubmed/35299288
http://dx.doi.org/10.1111/cts.13238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099120/
https://www.ncbi.nlm.nih.gov/pubmed/35299288
http://dx.doi.org/10.1111/cts.13238

Ejemplares similares